Spear Bio, founded in 2021, is a well-funded and rapidly growing start-up headquartered in Woburn, Massachusetts. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar levels from sub-microliter sample volumes, enabling unprecedented sensitivity. We are dedicated to revolutionizing early disease diagnosis and monitoring, empowering clinicians and researchers to improve patient outcomes, and advance global health. For more information, please visit www.spear.bio or email info@spear.bio.
| Website | http://www.spear.bio |
| Revenue | $5.1 million |
| Employees | 54 (44 on RocketReach) |
| Founded | 2021 |
| Phone | +1 978-406-1169 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Healthcare Technology, Life Sciences, Medical Technology, Precision Medicine, Biomedical Research, Molecular Diagnostics, Drug Discovery, Genetic Testing, Therapeutics, Dna Amplification, Biomarkers, In-Vitro Diagnostics, Genomics, Diagnostic Tools, Proteomics, Next Generation Sequencing, Molecular Biology, Clinical Diagnostics, Assay Development |
| Competitors | Roche, Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Bruker +44 more (view full list) |
Looking for a particular Spear Bio employee's phone or email?
The Spear Bio annual revenue was $5.1 million in 2026.
Feng Xuan is the Co-Founder and CEO of Spear Bio.
44 people are employed at Spear Bio.
Spear Bio is based in Boston, Massachusetts.